You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The Project Screen initiative aims to provide the Hong Kong community with home access to the World Health Organization-approved RT-PCR test for SARS-CoV-2 at zero profit to its organizers.
The firm noted a disruption in global business in late March, as customers closed or restricted access to their facilities in an attempt to slow the spread of the coronavirus.
Under the all-stock deal, Bard1 will acquire 100 percent of Sienna's ordinary shares in a transaction that values the company at about $14.8 million.
PharmaCyte, which develops therapies for cancer and diabetes, will be responsible for development and commercialization of tests based on the technology.
The company said that three of its clinical laboratories have passed a COVID-19 external quality assessment by China's National Center for Clinical Laboratories.
United said it will distribute the test to international governments and healthcare organizations.
Under the agreement, Bioneer will supply instruments, nucleic acid extraction reagents, and COVID-19 test kits, which will be placed at medical institutions in Qatar.
Both the Israeli and Palestinian authorities have granted approval for the lab to perform 3,000 COVID-19 tests per day for Gaza residents.
The diagnostic will be covered when patients are tested according to the Japanese Organization of Hereditary Breast and Ovarian Cancer's criteria.
Atomo also said it has closed an oversubscribed initial public offering and that it intends to float its shares on the Australian Securities Exchange mid-month.